Back

UBS ETF (IE) HFRX Global Hedge Fund Index SF UCITS ETF (hedged to GBP) A-acc

Net asset value 92.0454 GBP

Last update

16.04.2018

ISIN: IE00B53B4246

Asset Class:  Hedge Funds

General information

Name of fund

UBS ETFs plc – HFRX Global Hedge Fund Index SF UCITS ETF

Share class

UBS ETFs plc – HFRX Global Hedge Fund Index SF UCITS ETF (hedged to GBP) A-acc

ISIN

IE00B53B4246

Asset Class

Hedge Funds

Fund domicile

IE

Fund type

open-end

Reference Index

HFRX Global Hedge Fund Index hedged to GBP

UCITS IV

yes

Launch date

18.03.2011

Currency of share class

GBP

Accounting year end

30 June

Replication methodology

synthetic

Fund description

  • The investment objective of the Fund is to deliver the net total return performance of the HFRX Global Hedge Fund Index less fees and expenses.
  • The Fund replicates synthetically the index performance by investing in a swap.
  • Any exposure of the Fund to the swap counterparty is collateralised at min. 105% with UCITS compliant collateral.

Current fund data and tax figures

NAV Date

16 Apr 2018

Shares outstanding

55772

Official NAV per share

92.0454

Share class assets (GBP m)

5.13

Total fund assets (USD m)

72.89

Key benefits

  • Clients benefit from the flexibility of an exchange-traded investment.
  • Provides access to the performance of the index.
  • Optimised risk/return profile thanks to a broad diversification across a range of countries.
  • The fund offers a high degree of transparency and cost efficiency.
  • First ETF in the market providing access to the HFR Global Hedge fund Index.

Important information

Past performance is not a guide to future performance. The value of investments and the income from them may go down as well as up and are not guaranteed. Investors may not get back the amount originally invested. Changes in rates of exchange may cause the value of this investment to fluctuate. Some of the markets in which the Fund may effect derivative transactions are “over-the-counter” or “interdealer” markets, which may be illiquid and are sometimes subject to larger spreads than exchange-traded derivative transactions. The participants in such markets are typically not subject to credit evaluation and regulatory oversight, which would be the case with members of “exchange-based” markets. This exposes the Fund to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a credit or liquidity problem with the counterparty. Delays in settlement may also result from disputes over the terms of the contract (whether or not bona fide) since such markets may lack the established rules and procedures for swift settlement of disputes among market participants found in "exchange-based” markets. These factors may cause the Fund to suffer a loss due to adverse market movements while replacement transactions are executed or otherwise. The UBS ETF Sicav is a recognised scheme under section 264 of the Financial Services and Markets Act 2000. It does seek UK Reporting Fund Status. The protections offered by the UK’s regulatory system, and compensation under the Financial Services Compensation Scheme, will not be available. The information contained in this document should not be considered a recommendation to purchase or sell any particular security and the opinions expressed are those of UBS Asset Management and are subject to change without notice.

Performance chart (in fund currency)

These figures refer to the past. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units.

Fees

Flat fee p.a.1)

0.33%

Total expense ratio (TER) p.a.2)

0.34%

1) Due to a reduction of the management fee in 2013, an estimate is being used rather than an ex-post figure.

2) as at 31.12.2016

Registrations for public distribution

Country of distribution

Austria

Switzerland

Germany

France

United Kingdom

Ireland

Italy

Liechtenstein

Luxembourg

Netherlands

Sweden

Risks

The fund delivers the return of a broadly diversified hedge fund index and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. The returns payable on the fund are dependant on payments received by the fund from the swap counterparty under the terms of the relevant swap and, therefore, are subject to the credit risk of the swap counterparty. In the event that the swap counterparty defaults under the terms of the relevant swap, the fund may suffer a loss. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund’s assets are passively managed. As a result, the net asset value of the fund’s assets is materially dependent on the performance of the underlying investments. Losses that could be avoided via active management will not be offset.

Disclaimer

For marketing and information purposes. Prospectuses, simplified prospectuses or Key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS Fund Services (Luxembourg) S.A., P.O. Box 91, L-2010 Luxembourg or from UBS Asset Management (UK) Ltd, 21 Lombard Street, London, EC4R 9AH. The HFRX Global Hedge Fund Index is a trademark of Hedge Fund Research, Inc. and/or HFR Asset Management, LLC (“HFR”) and have been licensed by HFR to UBS solely for use in connection with its Product (“Product”). Other than this license, neither HFR nor the Index (which is complied independently of and without any regard to the Product) have any connection to the Product and have not participated in the Product’s creation and will not participate in it in any manner, including its on-going investment decisions and other administration and sales. The Product is not sponsored, endorsed, sold or promoted by HFR. HFR makes no express or implied recommendation, warranty or representation regarding the Product or the advisability of investing in it or its performance, including the results obtained by the Product. HFR has no obligation to advise the Product or any investor in the Product of any error in the Index. HFR has the right at any time to modify or change the Index, including the methodology used in its calculation, or to discontinue the calculation, publication and dissemination of the Index. HFR shall not be liable to the Product or to any investor in the Product for any damages of any kind or nature, including any error in the Index. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management © UBS 2018. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.